Day One Biopharma’s Executives Ramp Up Shares: CCO Buys 19k RSUs, CEO and COO Add Over 600k Shares in Quiet Surge【2†source】
Day‑one insider RSU buys at Day One Biopharmaceuticals signal executive confidence and reveal routine tax‑planning moves amid a volatile biotech cycle.
- Day One Biopharmaceuticals Inc
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- AI generated
5 minutes to read